Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
12/06/2026 10:34
BRIEF-Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility June 12 (Reuters) - Concord Biotech Ltd CONB.NS:
CONCORD BIOTECH - COMPLETES ANVISA INSPECTION AT LIMBASI API MANUFACTURING FACILITY
Source text: ID:nBSE6p6bxg
Further company coverage: CONB.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval